ArticleCardiovascular drugs and therapy2023

Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation.

Youzheng Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.